Go Pro

Rocket Pharmaceuticals (RCKT) Institutional Ownership

Rocket Pharmaceuticals logo
$3.84 0.00 (0.00%)
Closing price 07/2/2026 04:00 PM Eastern
Extended Trading
$3.76 -0.08 (-2.08%)
As of 07/2/2026 07:37 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Institutional Ownership Changes (13F Filings) for Rocket Pharmaceuticals (NASDAQ:RCKT)

Current
Institutional Ownership
Percentage
98.39%
Number of
Institutional Buyers
(last 12 months)
101
Total
Institutional Inflows
(last 12 months)
$71.91M
Number of
Institutional Sellers
(last 12 months)
72
Total
Institutional Outflows
(last 12 months)
$67.90M
Get RCKT Insider Trade Alerts

Want to know when executives and insiders are buying or selling Rocket Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Chart & View Institutional Buying and Selling Data

RCKT Institutional Buying and Selling by Quarter

Rocket Pharmaceuticals Major Shareholders & Ownership History

Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
6/2/2026Optiver Holding B.V.12,484$45K0.0%+584.1%0.011%
5/21/2026Essential Partners LLC13,541$48K0.0%+371.6%0.012%
5/19/2026Bank of America Corp DE630,125$2.26M0.0%+8.7%0.577%
5/18/2026ADAR1 Capital Management LLC432,500$1.55M0.1%-9.1%0.396%
5/16/2026The Manufacturers Life Insurance Company 149,204$534K0.0%-2.6%0.137%
5/16/2026Maverick Capital Ltd.3,567,372$12.77M0.1%+42.0%3.267%
5/16/2026Quantinno Capital Management LP76,248$273K0.0%+88.7%0.070%
5/15/2026Rice Hall James & Associates LLC91,887$329K0.0%+8.1%0.084%
5/14/2026Renaissance Technologies LLC637,174$2.28M0.0%+51.3%0.584%
5/14/2026Sei Investments Co.28,093$101K0.0%N/A0.026%
5/7/2026Dimensional Fund Advisors LP288,264$1.03M0.0%-14.9%0.264%
5/5/2026Bank of New York Mellon Corp239,842$859K0.0%-4.4%0.220%
5/5/2026Sanctuary Advisors LLC11,557$41K0.0%-33.7%0.011%
5/1/2026Sequoia Financial Advisors LLC20,349$73K0.0%+68.9%0.019%
4/28/2026Abel Hall LLC10,402$37K0.0%-26.5%0.010%
4/22/2026Ground Swell Capital LLC14,001$50K0.1%N/A0.013%
4/20/2026Assenagon Asset Management S.A.99,026$355K0.0%+204.6%0.091%
4/17/2026Krilogy Financial LLC15,963$62K0.0%N/A0.015%
4/16/2026SG Americas Securities LLC19,133$68K0.0%-70.0%0.018%
3/20/2026Hsbc Holdings PLC13,581$49K0.0%N/A0.013%
3/17/2026Rockefeller Capital Management L.P.64,222$225K0.0%-40.0%0.059%
3/9/2026Corient Private Wealth LLC28,024$98K0.0%N/A0.026%
2/19/2026Invesco Ltd.304,437$1.07M0.0%+36.9%0.281%
2/19/2026Corient Private Wealth LLC28,024$98K0.0%N/A0.026%
2/18/2026Virtus Investment Advisers LLC78,474$275K0.1%+111.7%0.073%
2/18/2026Tang Capital Management LLC100,000$351K0.0%-88.2%0.092%
2/18/2026Tudor Investment Corp ET AL42,411$149K0.0%-15.4%0.039%
2/18/2026Susquehanna Fundamental Investments LLC50,970$179K0.0%-57.4%0.047%
2/18/2026Suvretta Capital Management LLC2,992,735$10.50M0.2%-22.1%2.765%
2/18/2026Quadrature Capital Ltd65,376$229K0.0%-23.5%0.060%
2/18/2026Opaleye Management Inc.955,000$3.35M0.4%N/A0.882%
2/18/2026Millennium Management LLC1,784,921$6.27M0.0%-50.0%1.649%
2/18/2026Engineers Gate Manager LP96,009$337K0.0%+34.5%0.089%
2/18/2026Balyasny Asset Management L.P.400,706$1.41M0.0%-69.5%0.370%
2/18/2026Boothbay Fund Management LLC91,642$322K0.0%-7.2%0.085%
2/17/2026ADAR1 Capital Management LLC475,800$1.67M0.1%-17.4%0.440%
2/17/2026Schonfeld Strategic Advisors LLC149,413$524K0.0%N/A0.138%
2/17/2026PDT Partners LLC220,884$775K0.1%-17.0%0.204%
2/17/2026AQR Capital Management LLC703,528$2.47M0.0%-19.4%0.650%
2/17/2026Abel Hall LLC14,157$50K0.0%N/A0.013%
The $15 Gold Fund That Pays Up to $1,152/Month (Ad)

Gold is hitting record highs, but most investors are leaving income on the table. A $15 fund is quietly paying out up to $1,152 a month to regular investors - no mining stocks, no options, no physical metal required. Chief Income Strategist Tim Plaehn calls it a breakthrough strategy that transforms gold's rally into reliable monthly payouts. The next distribution is just days away.tc pixel

Discover the gold income fund before the next payout date
2/17/2026MPM Bioimpact LLC1,586,076$5.57M0.6%-59.4%1.466%
2/17/2026Jain Global LLC92,058$323K0.0%N/A0.085%
2/17/2026Jump Financial LLC118,200$415K0.0%-46.8%0.109%
2/17/2026Price T Rowe Associates Inc. MD944,873$3.32M0.0%-11.0%0.873%
2/17/2026Monimus Capital Management LP138,012$484K0.3%N/A0.128%
2/17/2026Russell Investments Group Ltd.10,229$36K0.0%-27.3%0.009%
2/17/2026Atom Investors LP36,480$128K0.0%-31.6%0.034%
2/17/2026ExodusPoint Capital Management LP178,926$628K0.0%-26.1%0.165%
2/17/2026Graham Capital Management L.P.73,743$259K0.0%-44.8%0.068%
2/16/2026Squarepoint Ops LLC68,317$240K0.0%-84.4%0.063%
2/16/2026Panagora Asset Management Inc.348,803$1.22M0.0%N/A0.322%
2/16/2026Mariner LLC12,634$44K0.0%-57.1%0.012%
2/16/2026Barclays PLC153,049$537K0.0%+2.4%0.141%
2/13/2026Prosight Management LP743,942$2.61M0.5%-41.3%0.687%
2/13/2026Maverick Capital Ltd.2,513,110$8.82M0.1%-70.3%2.322%
2/13/2026Marshall Wace LLP26,347$92K0.0%N/A0.024%
2/13/2026The Manufacturers Life Insurance Company 153,121$526K0.0%-2.2%0.141%
2/13/2026Walleye Capital LLC499,331$1.75M0.0%-20.2%0.461%
2/13/2026Stifel Financial Corp35,000$123K0.0%-10.7%0.032%
2/13/2026State Street Corp1,700,631$5.97M0.0%-2.6%1.571%
2/13/2026Ieq Capital LLC38,527$135K0.0%-52.5%0.036%
2/13/2026Dynamic Technology Lab Private Ltd38,110$134K0.0%+23.9%0.035%
2/13/2026Wells Fargo & Company MN103,906$365K0.0%+53.9%0.096%
2/13/2026Quadrant Capital Group LLC23,096$81K0.0%+44.0%0.021%
2/12/2026Jane Street Group LLC602,580$2.12M0.0%+18.7%0.557%
2/12/2026HRT Financial LP109,797$385K0.0%N/A0.101%
2/12/2026Brooklyn Investment Group19,199$67K0.0%-20.5%0.018%
2/12/2026MetLife Investment Management LLC33,480$118K0.0%-27.7%0.031%
2/12/2026Renaissance Technologies LLC421,174$1.48M0.0%+207.0%0.389%
2/12/2026Dimensional Fund Advisors LP338,830$1.19M0.0%-39.0%0.313%
2/12/2026EntryPoint Capital LLC96,354$338K0.1%-23.3%0.089%
2/12/2026Federated Hermes Inc.881,249$3.09M0.0%+40.4%0.814%
2/12/2026Marex Group plc57,500$202K0.0%+101.8%0.053%
2/11/2026Deutsche Bank AG474,866$1.67M0.0%+488.2%0.439%
2/11/2026Cerity Partners LLC22,792$80K0.0%+72.8%0.021%
2/11/2026LPL Financial LLC94,256$331K0.0%+628.6%0.087%
2/11/2026Franklin Resources Inc.10,848$38K0.0%N/A0.010%
2/11/2026JPMorgan Chase & Co.1,475,624$5.18M0.0%-29.6%1.364%
2/11/2026Los Angeles Capital Management LLC187,401$693K0.0%-29.1%0.173%
2/10/2026Goldman Sachs Group Inc.936,594$3.29M0.0%-26.3%0.865%
2/10/2026AXQ Capital LP33,277$117K0.0%-20.8%0.031%
2/10/2026Monaco Asset Management SAM2,987,296$10.49M1.8%+3.3%2.760%
2/9/2026Geode Capital Management LLC2,120,269$7.44M0.0%+10.7%1.959%
2/4/2026Pier 88 Investment Partners LLC47,880$168K0.0%+320.7%0.044%
2/3/2026Ballentine Partners LLC97,625$343K0.0%+10.2%0.090%
2/3/2026Sequoia Financial Advisors LLC12,051$42K0.0%N/A0.011%
2/3/2026Privium Fund Management B.V.170,146$597K0.1%-60.7%0.157%
1/29/2026Sanctuary Advisors LLC17,437$61K0.0%+63.5%0.016%
1/29/2026Concurrent Investment Advisors LLC68,096$239K0.0%-10.5%0.063%
1/27/2026Evergreen Capital Management LLC12,915$45K0.0%N/A0.012%
Read now. Do not delete. You’ve been warned. (Ad)

Three Nobel Prize Winners expose this once-in-a-generation wealth shift: “Don’t Say I Didn’t Warn You” Porter Stansberry exposes how the convergence of three immense forces is about to rewrite everything about the American way of life: how you work, save, invest… it’s all about to change.tc pixel

Don’t be left behind. Click here now.
1/14/2026Hennion & Walsh Asset Management Inc.309,247$1.09M0.0%+1.2%0.286%
1/9/2026SG Americas Securities LLC63,748$224K0.0%+30.8%0.059%
1/9/2026Assenagon Asset Management S.A.32,515$114K0.0%-9.2%0.030%
1/1/2026JPMorgan Chase & Co.2,097,033$6.84M0.0%+73.6%1.938%
12/15/2025Hudson Bay Capital Management LP34,700$113K0.0%+26.6%0.032%
11/21/2025CIBC Bancorp USA Inc.14,496$47K0.0%N/A0.013%
11/20/2025Voss Capital LP300,000$978K0.0%-40.0%0.277%
11/17/2025CANADA LIFE ASSURANCE Co7,626$25K0.0%-37.5%0.007%
11/17/2025Voleon Capital Management LP68,037$222K0.0%+70.0%0.063%
11/17/2025Susquehanna Fundamental Investments LLC119,613$390K0.0%-41.8%0.111%


RCKT Institutional Ownership - Frequently Asked Questions

During the previous two years, 241 institutional investors and hedge funds held shares of Rocket Pharmaceuticals. The most heavily invested institutionals were Wellington Management Group LLP ($84.22M), Janus Henderson Group PLC ($50.34M), Westfield Capital Management Co. LP ($32.15M), Perceptive Advisors LLC ($26.84M), Novo Holdings A S ($23.68M), Vanguard Group Inc. ($22.47M), and Point72 Asset Management L.P. ($19.73M).Learn more on Rocket Pharmaceuticals' institutional investors.

98.39% of Rocket Pharmaceuticals' stock is owned by institutional investors. Learn more on RCKT's institutional investor holdings.

Of the 206 institutional investors that purchased Rocket Pharmaceuticals' stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Wellington Management Group LLP ($4.84M), Maverick Capital Ltd. ($4.45M), Monaco Asset Management SAM ($2.99M), MPM Bioimpact LLC ($2.88M), Suvretta Capital Management LLC ($2.57M), JPMorgan Chase & Co. ($2.38M), and Toronto Dominion Bank ($2.20M).

Institutional investors have bought a total of 24,355,675 shares in the last 24 months. This purchase volume represents approximately $71.91M in transactions.

Of the 72 institutional investors that sold Rocket Pharmaceuticals' stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: Maverick Capital Ltd. ($5.96M), MPM Bioimpact LLC ($2.32M), Millennium Management LLC ($1.79M), Suvretta Capital Management LLC ($1.15M), Balyasny Asset Management L.P. ($913.03K), Prosight Management LP ($836.65K), and Tang Capital Management LLC ($750K).

Institutional investors have sold a total of 19,820,347 shares in the last 24 months. This volume of shares sold represents approximately $67.90M in transactions.



This page (NASDAQ:RCKT) was last updated on 7/5/2026 by MarketBeat.com Staff.
From Our Partners